 Anixa Biosciences, Inc. NASDAQ: ANIX, a biotechnology company focused on harnessing the bodys immune system in the fight against cancer, today announced that data from studies utilizing CchekTM, the companys artificial intelligence AI driven cancer detection technology, will be presented at the American Association for Cancer Research AACR Special Conference on Advances in Liquid Biopsies. The presentation will review data related to Anixas recently launched CchekTM Prostate Cancer Confirmation test. 